InvestorsHub Logo
Followers 4
Posts 883
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Tuesday, 11/12/2019 6:48:26 PM

Tuesday, November 12, 2019 6:48:26 PM

Post# of 1753
“It was another strong quarter, both in top line revenue growth and bottom line earnings versus last year,” said CEO Dr. Wayne Willkomm. He added, “We are hopeful for further growth versus last year, with the DOT (Department of Transportation) approval of our newest breathalyzers, which happened in the fourth quarter. These new breathalyzers are packed with features and power that make these top performers while still offering excellent value to our customers. But with the completion of these products, research and development expenses are not expected to drop. We continue to expect research spending to ramp up as we redirect existing resources and even add more resources to deploy against our top priority, which is the development and commercialization of our real-time drug testing, including the marijuana breathalyzer based on the SpinDx lab on a disc detection platform.”

This leads me to believe Lifeloc has a new line of breathalyzers that just received Department of transportation approval and are ready to start producing new revenue streams.

It is also very promising to hear that they are redirecting resources and adding more funding and effort to their top priority which is the SpinDX marijuana breathalyzer.

Fu*k yeah! That’s what I want to hear!

Let’s see if they can pull off submission of the Spin DX platform by the end of the year. Then it’s go time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News